•
Jun 30, 2024

Ovid Therapeutics Q3 2024 Earnings Report

Total Revenue
$169K
Previous year: $109K
+55.1%
EPS
-$0.2
Previous year: -$0.16
+25.0%
Gross Profit
$21K
Previous year: $109M
-100.0%
Cash and Equivalents
$77M
Previous year: $87.1M
-11.6%
Free Cash Flow
-$14.3M
Previous year: -$10.1M
+42.1%
Total Assets
$118M
Previous year: $125M
-5.5%

Ovid Therapeutics

Ovid Therapeutics